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VegfIn this work we describe a forward genetic approach to identify mutations that affect blood vessel
development in the zebraﬁsh. By applying a haploid screening strategy in a transgenic background that
allows direct visualization of blood vessels, it was possible to identify several classes of mutant vascular
phenotypes. Subsequent characterization of mutant lines revealed that defects in Vascular endothelial
growth factor (Vegf) signaling speciﬁcally affected artery development. Comparison of phenotypes
associated with different mutations within a functional zebraﬁsh Vegf receptor-2 ortholog (referred to as
kdr-like, kdrl) revealed surprisingly varied effects on vascular development. In parallel, we identiﬁed an
allelic series of mutations in phospholipase c gamma 1 (plcg1). Together with in vivo structure–function
analysis, our results suggest a requirement for Plcg1 catalytic activity downstream of receptor tyrosine
kinases. We further ﬁnd that embryos lacking both maternal and zygotic plcg1 display more severe defects in
artery differentiation but are otherwise similar to zygotic mutants. Finally, we demonstrate through mosaic
analysis that plcg1 functions autonomously in endothelial cells. Together our genetic analyses suggest that
Vegf/Plcg1 signaling acts at multiple time points and in different signaling contexts to mediate distinct
aspects of artery development.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe circulatory system provides oxygenation and waste removal
for developing organs and tissues, while serving as a conduit for
hormones and components of the immune system (Cleaver and Krieg,
1999). In addition, the endothelial cells lining nascent blood vessels
also serve as a source for important inductive and guidance signals
during organogenesis (Alt et al., 2006; Lammert et al., 2001).
Accordingly, blood vessel function is essential for vertebrate embryo-
nic development (Cleaver and Krieg, 1999). As organisms transition
from embryonic to adult stages, new blood vessel formation
(neovascularization) becomes more limited and in most cases this
process is associatedwith pathological conditions in the adult. As with
normal tissue and organs during embryonic development, ischemic
tissue or nascent tumors require increased vascularization and are
known to produce and secrete numerous angiogenic molecules that
promote blood vessel growth (Semenza, 2003). In most cases, the
signals that promote neovascularization in these pathological settings
in adults are the same that are used by the embryo (Cleaver and Krieg,
1999). Furthermore, the signaling molecules and cellular mechanisms. Lawson).
l rights reserved.by which blood vessels form have been evolutionarily conserved
(Weinstein and Lawson, 2002). Accordingly, it is has been possible to
gain signiﬁcant insights on pathological blood vessel formation
through the study of embryonic vascular development in vertebrate
model systems.
Among the important signaling molecules that are responsible for
neovascularization in both embryonic and adult settings are several
receptor tyrosine kinase families. These include receptors for vascular
endothelial growth factors (Vegf), angiopoietins and the membrane-
bound ephrin ligands (Yancopoulos et al., 2000). Vegf-A initiates and
induces endothelial cell differentiation at the earliest stages of blood
vessel development (Ferrara et al., 2003). Vegf-A acts by binding
Vegfr-2, an endothelial cell-speciﬁc receptor tyrosine kinase (Quinn
et al., 1993). Mice lacking either Vegf-A or Vegfr-2 display severely
reduced numbers of endothelial cells and fail to form blood vessels
(Carmeliet et al., 1996; Shalaby et al., 1995). Loss of speciﬁc Vegf-A
isoforms or endothelial autonomous ablation of Vegf signaling has
revealed later roles for this signaling pathway in arterial endothelial
cell differentiation and promoting endothelial cell survival, respec-
tively (Carmeliet et al., 1999; Lawson et al., 2002; Lee et al., 2007;
Stalmans et al., 2002). Furthermore, Vegf-A is also required for
angiogenic sprouting and plays an important role in modulating
vascular permeability in both adult and embryonic stages (Bates and
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pathway, the angiopoietins and their receptor, Tie2, mediate subse-
quent sprouting and maturation of the vascular network at later
stages of embryonic development. Angiopoietin/Tie2 signaling plays
an important role in crosstalk between endothelial cells lining the
blood vessels and associated vascular smooth muscle cells during
angiogenic sprouting (Davis et al., 1996; Maisonpierre et al., 1997; Suri
et al., 1996, 1998). Similarly, the Eph receptor tyrosine kinases and
their ligands, referred to as ephrins, mediate cell–cell signaling
between distinct cell types in the developing vascular system
(Yancopoulos et al., 1998). Eph–ephrin signaling plays an important
role in mediating the interface and separation between arteries and
veins (Gerety et al., 1999; Wang et al., 1998), as well as endothelial cell
interaction with surrounding mesenchymal cells (Adams et al., 1999;
Yancopoulos et al., 1998).
For the most part, the functional analysis of these and other
signaling pathways during vascular development has proceeded
largely through reverse genetic approaches using the mouse as a
model system. More recently, the zebraﬁsh has emerged as an ideal
model system for studying embryonic vascular development (Roman
and Weinstein, 2000). The transparency and external fertilization of
the zebraﬁsh embryo, coupled with the use of endothelial cell-speciﬁc
ﬂuorescent protein transgenes have allowed an unprecedented view
of blood vessel formation in a live organism (Beis and Stainier, 2006;
Lawson and Weinstein, 2002; Roman et al., 2002; Siekmann et al.,
2008). These particular aspects of the zebraﬁsh embryo havemade it a
tractable vertebrate model for forward genetic screening. Early
screens relying on the straightforward visualization of blood circula-
tion in the zebraﬁsh embryo led to the identiﬁcation of mutations that
affected cardiovascular morphogenesis or function (Chen et al., 1996;
Stainier et al., 1996). More recently, the use of transgene-assisted
screens (Jin et al., 2007) has allowed more subtle characterization of
defective vascular phenotypes in mutant zebraﬁsh embryos. The
ability to easily generate thousands of progeny embryos coupled with
the increasing quality of genomics tools has facilitated genetic
mapping and identiﬁcation of genes responsible for many of these
phenotypes (Patton and Zon, 2001).
In this study, we describe a haploid transgenic screen in zebraﬁsh
embryos to identify mutants that perturb normal vascular develop-
ment. This screening approach allowed robust and speciﬁc detection
of several different classes of mutant vascular phenotypes and the
majority of these were subsequently observed in diploid embryos.
Subsequent characterization and cloning of the genes responsible for
these mutant phenotypes revealed that the zebraﬁsh Vegf receptor,
kdr-like (kdrl), and phospholipase c gamma 1 (plcg1) were essential
for artery development. Interestingly, detailed phenotypic analysis of
different kdrl alleles suggested diverse roles for this receptor during
development of blood vessels. Parallel analysis of plcg1 alleles, along
with in vivo structure/function experiments, indicated a crucial role
for Plcg1 catalytic function downstream of receptor tyrosine kinases
during artery development. Furthermore, analysis of maternal–
zygotic plcg1 mutant embryos suggested an early role for Vegf/Plcg1
signaling during arterial speciﬁcation, while mosaic analysis revealed
an endothelial autonomous role for plcg1 during vascular morpho-
genesis. Taken together our results demonstrate the utility of a
transgenic haploid screening approach to identify mutants affecting
vascular development in the zebraﬁsh and underscore the diverse
roles of Vegf/Plcg1 signaling during artery development.
Materials and methods
Fish handling and care
All zebraﬁsh were maintained according to standard protocols
(Westerﬁeld, 1993) and in accordance with University of Massachu-
setts Medical School IACUC guidelines.Transgenic and mutant lines
Nomenclature for the zebraﬁshVegf receptororthologswas assigned
based on recently described guidelines (Bussmann et al., 2008). The
um19 allele is a 4 base pair deletion in exon 2 of kdrl that was generated
by targeted mutagenesis using zinc ﬁnger nucleases and is described
elsewhere (Meng et al., 2008). The Tg(ﬂi1a:egfp)y1 line has been
described elsewhere (Lawson and Weinstein, 2002). To generate
zebraﬁsh embryos with red ﬂuorescent blood vessels, we constructed
a plasmid containing a chimeric endothelial enhancer–promoter
fragment drivingdsRed-Express via Gatewaycloning into a Tol2 plasmid
backbone (Villefranc et al., 2007). The resulting plasmid (pTolﬂi1ep:
dsredex) was co-injected into 1-cell stage wild type zebraﬁsh embryos
along with mRNA encoding the Tol2 transposase (Kawakami et al.,
2004). Embryos with the highest and least mosaic expression were
grown to adulthood and founders were identiﬁed by out-crossing. The
Tg(ﬂi1ep:dsredex)um13 line was derived from a single founder.
Mutagenesis and screening
ENU mutagenesis was performed based on previously described
protocols (Solnica-Krezel et al., 1994). Brieﬂy, we treated homozygous
Tg(ﬂi1a:egfp)y1 adult males with 3 mM N-ethyl-N-nitrosourea (ENU)
for 1 h once a week for a total of 4 weeks. Following a two-week
recovery, ﬁsh were bred to wild type females to purge mutagenized
gametes that usually harbor gross chromosomal aberrations (Imai et
al., 2000). ENU-treated males were then crossed to homozygous Tg
(ﬂi1a:egfp)y1 females to generate an F1 generation. Beginning at
6 months of age, F1 Tg(ﬂi1a:egfp)y1 females were used to generate
haploid embryos by performing in vitro fertilization (Westerﬁeld,
1993) using UV irradiated sperm. Each individual F1 Tg(ﬂi1a:egfp)y1
female that successfully gave viable haploids was maintained in an
individual tank. Subsequently, Tg(ﬂi1a:egfp)y1 embryos were screened
at 30 h post fertilization and again at 50 hpf for defects in segmental
artery formation, as well as overall morphology using a stereo
dissection microscope equipped with epiﬂuorescence. F1 Tg(ﬂi1a:
egfp)y1 females that gave clutches of embryos in which 50% displayed
a mutant vascular phenotype were subsequently out-crossed to TL
males to generate a map cross. Females that gave mutant phenotypes
that exhibited general morphological defects or necrosis were not
maintained. Genetic linkage mapping and candidate cloning of genes
was carried out as described elsewhere (Lawson et al., 2003; Roman
et al., 2002).
Phenotypic analysis and microscopy
All diploid mutant embryos were analyzed at 30 hpf using a
dissection microscope equipped with epiﬂuorescence (Leica MZFLIII,
1× PlanApo) to determine presence of segmental arteries. Embryos
were also observed with transmitted light at 55 hpf to observe
circulatory patterns and overall morphology. Vascular morphology
defects were documented in more detail using a Leica DMIRE2
microscope equipped with a TCS SP2 confocal laser scanning system
(Objective: HC PL APO 20×/0.70 CS, dry). In most cases, vertical
projections of confocal stacks were generated using Leica Confocal
Software (LCS). Alternatively, vertical projections were generated
using the Imaris software package (Bitplane). Sprout length was
measured in 3-dimensional stacks using Imaris. For this purpose, 6
pairs of segmental artery sprouts were counted in at least 3 embryos
from 3 different clutches. Length was measured as distance of a
perpendicular line from the dorsal wall of the dorsal aorta to the distal
end of the segmental artery. Overall morphology was documented by
capturing digital images using transmitted light on a MZFLIII
dissection microscope equipped with a Zeiss Axiocam mRC digital
camera using Axiovision software (Zeiss). More detailed morpholo-
gical imaging was performed by differential interference contrast
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(Achroplan 20×/0.5 water; Achroplan 40×/0.8 water) equipped with
a Zeiss Axiocam hRC digital camera. All images were exported from
Axiovision, LCS, or Imaris as TIF ﬁles and imported into Photoshop CS2
(Adobe) to generate ﬁgures.
Riboprobes
Antisense riboprobes against ephrinb2a, dll4, and notch3, were
generated as described previously (Lawson et al., 2001; Siekmann and
Lawson, 2007). Whole mount in situ hybridization was performed as
described elsewhere (Hauptmann and Gerster, 1994). DIC images of
stained embryos were captured as described above.
Generation of germ cell plcg1 mutants
To generate adults bearing plcg1 deﬁcient germ cells, we utilized
the germline replacement strategy described elsewhere (Ciruna et al.,
2002). Brieﬂy, embryos from an incross of non-transgenic plcg1y18
carriers were injected withmRNA encoding EGFPwith the 3′UTR from
the nanos transcript. In parallel, wild type embryos were injected with
a morpholino targeting the dead end gene to ablate host germ cells.
Donor cells from the margin of sphere stage embryos derived from
putative plcg1y18 carriers were transplanted into the margin of host
wild type embryos. Donor and host embryos were then allowed to
develop until 24 to 48 hpf. Host embryos were grown to adulthood if
the corresponding donor embryo was found to be mutant for plcg1 by
visual inspection and the host embryos displayed evidence of
transplanted germ cells as indicated by green ﬂuorescence. Putative
maternal (M) or paternal (P) mutant founders were identiﬁed by
crossing them to heterozygous plcg1y18 mutant carriers. In all cases,
Mplcg1y18 and Pplcg1y18 carriers displayed fully penetrant plcg1
mutant phenotypes indicating that all germ cells were mutant.
Plcg1 rescue experiments
Previously described mutations in the SH2 (Ji et al., 1999) and SH3
(Ye et al., 2002) domains of Plcg1 were introduced into zebraﬁsh plcg1
coding sequence by overlapping PCR and all constructs were validated
by sequencing. Mutant constructs were generated in the pCS-mtplcg1
backbone (Lawson et al., 2003). All plasmids were linearized with Not
I andmRNA synthesized using the mMessagemMachine kit (Ambion)
to drive transcription from the SP6 promoter. We injected 400 pg of
mRNA into 1-cell stage embryos derived from an incross of plcg1y18
heterozygous carriers. As controls, embryos were injected with mRNA
encoding wild type Plcg1, or left uninjected. Embryos were scored at
30 hpf for segmental artery formation; embryos were classiﬁed as
having no segmental arteries (SeA−), partial segmental arteries, with
no dorsal longitudinal anastomotic vessel (SeA+DLAV−), or wild
type (SeA+DLAV+). At 55 hpf, embryos were scored for blood
circulation and classiﬁed with normal circulation (circ+), evidence of
shunting between the dorsal aorta and posterior cardinal vein
(partial), or no circulation (circ−). Following phenotypic analysis,
all embryos were subjected to PCR-screening for genotyping.
To generate expression constructs for activated forms of Akt or
MAP2K1, we ﬁrst generated Gateway entry clones. A constitutively
membrane-localized form of Akt was PCR-ampliﬁed from a plasmid
template (kindly provided by Fumihiko Urano, UMassMedical School)
using the following primers: 5′-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTCCGCGTTTAGCTTATGGGGAG and 5′-GGGGACCACTTTGTAC-
AAGAAAGCTGGGTAGGCTGTGCCACTGGCTGAGT, where Akt coding
sequence are underlined and the endogenous start codon is in bold.
An activated form of human MAP2K1 was ampliﬁed from plasmid
template (kindly provided by Roger Davis, UMass Medical School)
using primers 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTc-
cAAAATGCCCAAGAAGAAGC and 5′-GGGGACCACTTTGTACAAGAAA-GCTGGGTTTAGACGCCAGCAGCATGGGT; hMAP2K1 sequence is
underlined, endogenous start codon is in bold. In both cases, the
forward primer contains an attB1 site, while the reverse primer
contains an attB2 site. PCR products were subjected to BP cloning
to generate pMEmAkt and pMEactMAP2K1 entry clones, which
were sequence validated. Entry clones were then used in Gateway
LR reactions to generate expression clones. For actMAP2K1, we
constructed N-terminal monomeric Cherry fusion proteins by
recombining pMEactMAP2K1 with either pCSCherDest (to give
pCS-mcher-actMAP2K1) or pTolﬂi1epCherDest (to give pTol-ﬂi1ep:
mcher-actMAP2K1) (Villefranc et al., 2007). For mAkt, we utilized
multisite Gateway cloning to generate a tandem, unfused mAkt-
mCherry cassette using the viral 2A peptide sequence (Provost et al.,
2007). For this purpose, we recombined pMEmAkt with pCSDest2
(Villefranc et al., 2007) and p3E-2a-mcherry (kindly provided by
Chi-Bin Chien, University of Utah) to give pCS-mAkt-2a-mcher. To
generate an endothelial cell-speciﬁc construct, we recombined
pMEmAkt with p5Eﬂi1ep, which contains a chimeric fragment of a
ﬂi1a enhancer and promoter (Villefranc et al., 2007), pDest Tol2pA
(Kwan et al., 2007), and p3E-2a-mcherry to give pTol-ﬂi1ep:mAkt-2a-
mcherry. We utilized pCS-mCher-actMAP2K1 and pCS-mAkt-2a-
mcherry for mRNA synthesis as described elsewhere (Villefranc et al.,
2007) and mRNA was injected at 1- to 2-cell stage into wild type
embryos. For pTol-ﬂi1ep:mAkt-2a-mcher and pTol-ﬂi1ep:mcher-act-
MAP2K1, we co-injected 25 pg of circular plasmid DNAwith 25 pg Tol2
transposasemRNA into 1-cell stage embryos derived from an incross of
plcg1y13 heterozygous carriers. Injected embryos were observed for
segmental artery formation and circulation as described above.
Genotyping
The plcg1y13 mutation eliminates a PstI site within the X-catalytic
domain. PCR was performed using primers 5′-CTGCGTTCAGCTATCC-
CATC and 5′-CCTCTTGAGCTGGTGTGGCGA and the resulting product
was digested with PstI. The plcg1y16mutation eliminates an EagI in the
N-terminal SH2 domain. For y16 genotyping, primers 5′-GTATGGAC-
CAGCATGTGACGGAG and 5′-CTACAAAGGTCTCGCTCTCCCGC were
used for PCR and the resulting fragment was digested with EagI. For
genotyping the plcg1y18 allele, we ampliﬁed a CA repeat within plcg1
(primers: 5′-TGTAGGATCTGAGGTTTGAT and 5′ TGAGATCCTT-
GAGCCTGGGG) that was polymorphic in our background strain.
Alternatively, we utilized a single nucleotide polymorphism (SNP)
within a StyI site in plcg1 in our crosses (5′-GCAACGAGTTCGAGAT-
GAAGC and 5′-GTGTGGACGCATAGCCCTC). Genotyping of the kdrl
alleles was performed as described elsewhere (Covassin et al., 2006;
Meng et al., 2008).
Mosaic analysis
For mosaic analysis of plcg1 deﬁcient cells in wild type vasculature,
donor Tg(ﬂi1a:egfp)y1 embryos were prepared by injecting with the
lineage tracer Cascade Blue (Molecular Probes/Invitrogen) and 7.5 ng of
a plcg1morpholino targeting the exon 1 splice donor site (Lawson et al.,
2003) at 1- to 2-cell stage. At sphere stage, cells were removed from
donor embryos and transferred towild type Tg(ﬂi1ep:dsredex)um13 hosts
using a glass capillary. For analysis of wild type cells in plcg1-deﬁcient
vasculature, donor Tg(ﬂi1a:egfp)y1 embryos were injected with the
lineage tracer Cascade Blue. Subsequently, donor cells were placed into
Tg(ﬂi1ep:dsredex)um13 embryos that had been injected at the 1-cell stage
with the plcg1morpholino. As a control, cells for Cascade Blue-injected
wild type Tg(ﬂi1a:egfp)y1 embryos were transplanted into uninjected
wild type Tg(ﬂi1ep:dsredex)um13 host embryos. In all cases, embryos
were grown to 26 to 28 hpf at which time position of GFP+ donor cells
was determined through visualization by confocal microscopy as
described above. Emission from GFP, dsRedEx, and Cascade Blue was
acquired by sequential scanning using a 488 nm, 561 nm and 405 nm
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generate vertical projection and overlays using the included Leica
software, Imaris, or Photoshop CS2.
Results
A haploid transgenic screen to identify mutants that affect embryonic
vascular development
Previous forward screening strategies to identify vascular mutants
in zebraﬁsh have relied on observation of circulatory defects in F3
embryos as a primary screen (Chen et al., 1996; Jin et al., 2007; Stainier
et al., 1996). However, the two-generation breeding scheme used in F3
screens is labor- and cost-intensive and can take several years to
screen sufﬁcient numbers of genomes. In an effort to more easily
screen for vascular mutants in zebraﬁsh, we took advantage of the
ability to generate haploid embryos to allow screening of progeny
from F1 females. Additionally, we utilized Tg(ﬂi1a:egfp)y1 zebraﬁsh
(Lawson andWeinstein, 2002) to allow direct visualization of putative
vascular phenotypes in developing haploid embryos derived from F1
females.
To induce mutations in the male zebraﬁsh germline, we treated
homozygous Tg(ﬂi1a:egfp)y1 males with N-ethyl-N-nitrosourea
(ENU). Subsequently, we used ENU-treated males to generate F1
families (Fig. 1A). To identify mutations that would lead to blood
vessel defects, we generated haploid embryos from individual Tg
(ﬂi1a:egfp)y1 F1 females and screened for segmental artery formation
at 1 or 2 days post fertilization. In general, we found that the overall
morphology of haploid Tg(ﬂi1:egfp)y1 zebraﬁsh embryos was rela-
tively normal, although body length was shortened and somiteFig. 1. A transgenic haploid screen for vascular mutants. (A) Breeding strategy for transgen
Segmental arteries (red arrowheads) in awild type Tg(ﬂi1a:egfp)y1 haploid embryo. Red brac
(E) Partial segmental artery sprouts (red arrowheads) in a y16 mutant haploid embryo. (F
segmental artery formation and failure to form the dorsal aorta in a y11 haploid mutant emb
micrographs. (F) Epiﬂuorescent image. (B) Scale bar is 250 μM. (C–G) Scale bar is 50 μM.formation, as well as head development was often mildly perturbed
(Fig. 1B and data not shown). Despite these mild abnormalities, trunk
blood vessel morphology and segmental artery formation was robust
in wild type Tg(ﬂi1:egfp)y1 haploid embryos allowing for straightfor-
ward identiﬁcation of mutant vascular phenotypes (Figs. 1C–G). In
total, we screened approximately 1200 mutagenized genomes and
identiﬁed 17 females that produced clutches in which half of the
haploid embryos displayed speciﬁc defects in vascular morphology. In
all cases, general morphology of the mutant embryos was comparable
to their wild type siblings (data not shown). We were able to identify
4 classes of mutant phenotypes in clutches of haploid embryos from
F1 Tg(ﬂi1:egfp)y1 females. Class I mutants such as y10, displayed a
complete loss of segmental artery formation (Fig. 1D, Table 1) while
the level of transgene expressionwas comparable to wild type siblings
indicating the presence of endothelial cells within the presumptive
dorsal aorta and posterior cardinal vein. In Class II mutants, such as
y16, we observed partial segmental artery formation (Fig. 1E). A
single Class III mutant, um7, displayed ectopic branching of segmental
arteries (Fig. 1F). The y11mutant (Class IV) exhibited the most severe
effect on vascular development with a complete loss of segmental
arteries, defective formation of the major trunk vessels (Fig. 1G), as
well as loss of cranial blood vessels (data not shown).
To conﬁrm that the vascular defects observed in haploids would
persist in diploid embryos and to facilitate genetic mapping, we out-
crossed putative F1 female mutant carriers to a genetically diverse
wild type line (TL; Fig. 1A). We were able to obtain viable F2 families
from 14 out of 17 females. In clutches of embryos from 10 out of the 14
families, we observed defective vascular phenotypes that were similar
or identical to those observed inmutant haploid embryos (see below).
Subsequent bulk segregant analysis, ﬁne genetic mapping and/oric haploid screen. (B) Transmitted light image of a Tg(ﬂi1a:egfp)y1 haploid embryo. (C)
ket denotes dorsal aorta. (D) Loss of segmental arteries in a y10mutant haploid embryo.
) Excessive segmental artery branching in a um7 mutant haploid embryo. (G) Loss of
ryo. (B–G) Lateral views, anterior to the left, dorsal is up. (C–E, G). Confocal ﬂuorescent
Table 1
Segmental artery mutants identiﬁed by haploid transgenic screening.
Class Gene Allele Mutation Affected domain SeA Reference
I kdrl um6 C1117→G Cytoplasmic None Meng et al., 2008; this study
plcg1 y10 SA PH None Lawson et al., 2003
y13 C412→R X-catalytic None This study
y15 I383→N X-catalytic none –
y18 SD All None Covassin et al., 2006; this study
y19 ND All None –
II kdrl y17 L846→R ATP binding Partial Covassin et al., 2006; this study
plcg1 y16 R557→H N-SH2 Partial this study
III plexinD1 um7 ND ND Ectopic –
IV etsrp y11 Insertion DNA binding Partial Pham et al., 2007
SA — splice acceptor; SD — splice donor; ND — not determined.
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responsible for the observed vascular defects. The y11mutation lies in
the endothelial cell-speciﬁc transcription factor, ets-related protein
(etsrp), leading to global defects in endothelial gene expression,
apoptosis of endothelial cells, and defects in vascular morphogenesis
(Pham et al., 2007). Consistent with the ectopic sprouting defects
observed in um7 mutants, we ﬁnd that this mutation maps to the
plexind1 locus (data not shown), a gene previously implicated in
proper segmental artery patterning in zebraﬁsh (Torres-Vazquez et al.,
2004). We found that Class I and II mutants that displayed defects in
segmental artery formation mapped to two genes implicated in VegfFig. 2. Mutations in kdrl affect segmental artery formation. (A–D) Confocal ﬂuorescent mic
views, anterior to the left, dorsal is up. Scale bar is 50 μM. (A) Wild type Tg(ﬂi1a:egfp)y1 dip
dorsal aorta (DA) is indicated by a red bracket. (B) Segmental arteries in a kdrlum6;Tg(ﬂi1a:eg
arrowheads indicate somite boundaries at which segmental arteries failed to sprout. Red bra
(white arrows) in a kdrlum19;Tg(ﬂi1a:egfp)y1 diploid mutant embryo. Awell-formed dorsal ao
embryo with both fully formed (indicated by asterisks) and partial segmental arteries (whi
Quantiﬁcation of sprout length in kdrl mutant embryos and their wild type siblings. (F) L
alignment of conserved regions from Vegf-receptor-2/Kdr and Vegf-receptor-3/Flt4 from zsignaling, plcg1 and kdrl. Based on our previous ﬁndings concerning
the role of Vegf in artery development, we focused on the detailed
genetic and phenotypic characterization of these mutants.
Mutations in a zebraﬁsh Vegf receptor-2 ortholog cause defects in artery
development
We have previously found that a mutation in a zebraﬁsh Vegf
receptor, referred to as kdr-like (previously referred to as ﬂk1 or kdra)
is responsible for partial segmental artery defects associated with the
y17 mutant identiﬁed in our haploid screen (Table 1(Covassin et al.,rographs of zebraﬁsh embryonic trunk blood vessels at 30 h post fertilization. Lateral
loid sibling embryo. Arrowheads indicate DLAV. Arrows denote segmental arteries and
fp)y1 diploid mutant embryo. Partial segmental arteries indicated by white arrows. Red
cket indicates a trunk vessel with a single lumen. (C) Partial segmental artery formation
rta (red bracket) is apparent in this embryo. (D) A kdrly17;Tg(ﬂi1a:egfp)y1 diploid mutant
te arrows). The red arrow indicates region of the dorsal aorta that is discontinuous. (E)
ocation of the um6 mutation within the zebraﬁsh Kdrl cytoplasmic domain. ClustalW
ebraﬁsh (Dr), human (Hs), rat (Rn), and mouse.
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screen, only um6 failed to complement y17 (data not shown),
indicating that it also was a mutation in kdrl. Interestingly, the um6
mutation appeared to lead to more severe defects in segmental artery
formation in haploid embryos than those associated with y17 (Table
1). Therefore, to better evaluate the effects of the kdrlum6 and kdrly17
mutations on vascular development, we compared them to a null kdrl
allele that we generated through targeted mutagenesis using zinc
ﬁnger nucleases (Meng et al., 2008). The um19 allele is a 4 base pair
deletion in exon 2 of kdrl and introduces a frameshift that truncates
the Kdrl receptor tyrosine kinase in the extracellular domain.
We ﬁrst compared defects in vascular morphogenesis associated
with each kdrl allele in mutant embryos bearing the Tg(ﬂi1:egfp)y1
transgene. In wild type siblings at 30 h post fertilization, a basic
vascular network consisting of the dorsal aorta, segmental arteries
and the dorsal longitudinal anastomotic vessel (DLAV) was evident
(Fig. 2A). The kdrlum6 mutation appeared to have the most severe
effect on segmental artery formation leading to variable formation of
partial segmental arteries in most embryos (Fig. 2B, white arrows
indicate partial segmental arteries). In many cases, small ﬁlopodial
extensions were observed at the usual site of segmental artery
formation, but sprouts failed to emanate from the dorsal aorta (Fig. 2B,Fig. 3. Defects in circulatory function in kdrlmutants. (A–G) Transmitted light images of wild
to the left, dorsal is up. (A) Wild type sibling embryo. Scale bar is 250 μM. (B) kdrlum6 muta
region of wild type sibling embryo. Scale bar is 50 μM. (D) Cranial hemorrhage (white arrow
kdrlum19mutant embryo. (G) Eye and forebrain region of a kdrlum19mutant embryo. A cranial
clutches of embryos derived from incrosses of um6, um19, and y17 heterozygous carriers;
posterior cardinal vein, hem — cranial hemorrhage.red arrowheads). kdrlum6 mutant embryos also failed to display a
distinctly separated dorsal aorta and posterior cardinal vein and
instead a single major trunk vessel was evident (Fig. 2B, red bracket).
We observed that defective segmental artery formation due to the null
kdrlum19 mutation was similar to kdrlum6 mutant embryos, although
partial sprouts were consistently observed within every segment
(Fig. 2C). Interestingly, morphogenesis of the dorsal aorta and
posterior cardinal veinwas largely normal in kdrlum19mutant embryos
(Fig. 2C). Embryos mutant for kdrly17 displayed the mildest segmental
artery defects, with variable formation of DLAVs and partial segmental
artery formation evident (Fig. 2D). However, dorsal aorta morpho-
genesis appeared abnormal as we observed its discontinuous
formation in kdrly17 mutant embryos (Fig. 2D, red arrowhead). This
observation is consistent with our previous ﬁnding of arteriovenous
shunting between the dorsal aorta and posterior cardinal vein in
kdrly17 mutant embryos (Covassin et al., 2006). Quantiﬁcation of
segmental artery length in each mutant conﬁrmed that the um6
mutation most severely affected segmental artery formation, while
um19 and y17 had increasingly milder effects (Fig. 2E). Subsequent
molecular analysis of the kdrl coding sequence in um6 mutant
embryos revealed a T to G transversion resulting in a missense
mutation that changed cysteine to glycine at amino acid 1117 withintype and kdrlmutant zebraﬁsh embryos at 55 h post fertilization. Lateral views, anterior
nt embryo displaying cardiac edema (white arrow). (C) Eye (indicated) and forebrain
s) in a heterozygous carrier of the kdrlum6 allele. (E) kdrlum6 heterozygous embryo. (F)
hemorrhage is indicated by the white arrow. (H) Quantiﬁcation of circulatory defects in
circ — circulation, shunt — abnormal circulatory connection between dorsal aorta and
218 L.D. Covassin et al. / Developmental Biology 329 (2009) 212–226the Kdrl cytoplasmic domain (Table 1). This cysteine residue is
identical in the related zebraﬁsh vegf-receptor 2 ortholog, kdr, as well
as related Vegf receptors in zebraﬁsh, mouse, and human (Fig. 2F).
Our analysis of vascular morphology in kdrl mutants revealed a
surprisingly differential effect on angiogenic formation of segmental
arteries and dorsal aorta morphogenesis. To further assess how these
alleles affect vascular morphogenesis and function, we assayed
circulatory defects in kdrl mutant embryos. At 55 hpf, wild type
embryos displayed a functional circulatory system that carries
hemoglobinized red blood cells (Fig. 3A and data not shown). By
contrast, kdrlum6 mutant embryos failed to exhibit any active
circulation and display pericardial edema (Fig. 3B and data notFig. 4. plcg1 is required for segmental artery formation. (A) Functional domains within Plcg1.
2 domains; SH3 — src homology 3 domain. Residues affected by the y13 and y16 mutation
zebraﬁsh, Hs— human, Dm— Drosophila, Mm—mouse). The y18 allele leads to a truncation i
at 30 h post fertilization. Lateral views, anterior to the left, dorsal is up. (B)Wild type sibling e
Partial segmental arteries (white arrows) in a plcg1y16 mutant embryo. (E) plcg1y18 mutant
SH2 and SH3 domains. (G) Graph indicating proportion of embryos displaying segmental a
construct. (H) Graph indicating proportion of embryos displaying partial or complete circu
segmental arteries, DLAV — dorsal longitudinal anastamotic vessel, circ — circulation, partiashown). Closer inspection of embryos derived from kdrlum6 hetero-
zygous carriers revealed that approximately ﬁve percent of all
embryos with otherwise normal circulatory ﬂow displayed cranial
hemorrhage (compare Figs. 3C and D; Fig. 3H). Subsequent genotyp-
ing of these embryos revealed that they were heterozygous for the T to
G transversion (data not shown) suggesting that the kdrlum6mutation
can act as a mild dominant negative. Despite the moderate severity of
the segmental artery defects in kdrlum19 mutant embryos, this
mutation had the mildest effect on circulatory function consistent
with normal dorsal aorta morphogenesis in these embryos (Fig. 2C).
At 55 hpf all kdrlum19 mutant embryos displayed normal circulation
throughout the vascular system with no evidence of cardiac edemaPH— pleckstrin homology domain; X, Y— split catalytic domains; SH2— src homology–
s are outlined in red and aligned with conserved sequences from other species (Dr —
n the X-catalytic domain. (B–E) Confocal ﬂuorescent micrographs of trunk blood vessels
mbryo. Scale bar is 50 μM. C. Loss of segmental arteries in a plcg1y13mutant embryo. (D)
embryo. (F) Position of point mutations engineered into rescue constructs in the Plcg1
rtery or DLAV formation following injection with mRNA encoding the indicated Plcg1
lation following injection with mRNA encoding the indicated Plcg1 construct; SeA —
l — shunt between dorsal aorta and posterior cardinal vein.
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mately ﬁfteen percent of all embryos, indicating a partially penetrant
defect in vascular function in kdrlum19 mutants (Figs. 3G, H).
Consistent with our previous study, we observed variable circulatory
defects in kdrly17 mutant embryos, including some embryos with
complete lack of circulation, presence of arteriovenous shunts
between the dorsal aorta and posterior cardinal vein, and cranial
hemorrhage (Fig. 3H and data not shown). Taken together, our results
indicate that these alleles differentially affect blood vessel formation
in the developing embryo.
Mutations in phospholipase c gamma 1 perturb artery development
Our previous work demonstrated that the y10 mutation (Fig. 1C,
Table 1) lies in a splice donor site within the phospholipase c gamma 1
(plcg1) gene leading to a speciﬁc defect in artery development
(Lawson et al., 2003). Plcg1 mediates signaling downstream of a
number of different receptor tyrosine kinases, including receptors for
platelet derived growth factors (Pdgfs), ﬁbroblast growth factors
(Fgfs) and Vegf itself (Rhee, 2001; Wilde and Watson, 2001). Plcg1
interacts with phosphorylated tyrosine residues on an activated
receptor tyrosine kinase via its SH2 domains. Subsequent activation of
Plcg1 occurs through phosphorylation of tyrosine residues by the
upstream receptor tyrosine kinase. This results in induction of Plcg1
catalytic activity leading to cleavage of phosphoinositide-4,5-bispho-
sphate (PIP2) to form inositol-3-phosphate (IP3) and diacylglycerol
(DAG), second messengers that ultimately induce calcium release and
activation of protein kinase C isoforms, respectively (Rhee, 2001).
More recently, Plcg1 has been shown to transduce signals mediated by
other upstream activators through interaction with its SH3 domain
and can function in a catalytic domain independent manner in this
regard (Patterson et al., 2002; Ye et al., 2002).
We found that ﬁve additional mutants failed to complement
plcg1y10 or displayed genetic linkage to plcg1 (data not shown and
Table 1). The y13, y15, and y16 alleles are point mutations in the plcg1Fig. 5. Activation of Akt or MAPK signaling fails to rescue segmental artery formation in plcg
30 h post fertilization. Anterior is to the left, dorsal is up. Scale bar is 60 μM. (A–C) Wild type
mCher-actMAP2K1; arrow denotes excessive ﬁlopodial extensions in a sprout expressing hig
egfp)y1;plcg1y13mutant embryo co-injected with 25 pg Tol2 transposase mRNA and pTol-ﬂi1e
of the aorta. (G–I) Tg(ﬂi1a:egfp)y1;plcg1y13mutant embryo co-injectedwith 25 pg Tol2 transp
cells in the dorsal aorta.coding sequence that change conserved amino acid residues in
relevant functional domains (Table 1; Fig. 4A and data not shown).
Both plcg1y13and plcg1y15 are in the X region of the split catalytic
domain essential for lipase activity (Rhee, 2001). In y13 mutant
embryos C412 is mutated to R, while y15 changes I383 to N. In both
cases, these residues are identical in the catalytic domains of related
phospholipases across a wide variety of species (Fig. 4A and data not
shown). The plcg1y16mutation changes R557 to H in the N-terminal Src
homology 2 (SH2) domain. Based on crystal structure of the
homologous SH2 domain in Src (Waksman et al., 1993), this residue
is important for direct binding to phosphorylated tyrosine residues.
The y18 allele is a G to A transition in the consensus splice donor site
(GT) for exon ENSDARE00000761392 (ENSEMBL, Zv7) and leads to a
deletion in the X-catalytic domain and premature truncation of the
coding sequence (Fig. 4A and data not shown). The y19 mutation
results in a small deletion in the plcg1 coding sequence, although we
have not identiﬁed the genomic lesion in this mutant.
All plcg1 mutant embryos exhibited speciﬁc defects in artery
development, but overall normal morphology was normal (data not
shown). Wild type sibling embryos displayed a fully formed
segmental artery network at 30 hpf (Fig. 4B) while embryos mutant
for plcg1y13 (Fig. 4C) or plcg1y18 (Fig. 4E) failed to form segmental
artery sprouts. In addition, plcg1y13 and plcg1y18 mutant embryos do
not initiate blood circulation. Consistent with the observed haploid
phenotype (see Fig. 1E), the plcg1y16 mutation caused weaker defects
in artery development as all mutant embryos display partial
segmental artery sprouts at 30 hpf (Fig. 4D). Most embryos mutant
for plcg1y16 failed to initiate circulation, although we observed mutant
embryos with arteriovenous shunts between the dorsal aorta and
posterior cardinal vein (data not shown).
Plcg1 can mediate Vegf signaling through direct interaction with
Kdr in human endothelial cells (Takahashi et al., 2001) and can also
interact with the related Vegf receptor, Flt4 (Borg et al., 1995).
Accordingly, we have found that combined loss of Kdrl and Flt4
recapitulates segmental artery phenotype observed in plcg1 mutant1y13 mutant embryos. (A–I) Confocal ﬂuorescent micrographs of trunk blood vessels at
Tg(ﬂi1a:egfp)y1 embryo co-injected with 25 pg Tol2 transposase mRNA and pTol-ﬂi1ep:
h levels of the transgene; arrowhead is a low transgene-expressing cell. (D–F) Tg(ﬂi1a:
p:mCher-actMAP2K1. (E, F) Arrows indicate transgene-expressing cells in the dorsal wall
osasemRNA and pTol-ﬂi1ep:mAkt-2A-mCher; (H, I) Arrows denote transgene-expressing
220 L.D. Covassin et al. / Developmental Biology 329 (2009) 212–226zebraﬁsh embryos(Covassin et al., 2006). However, these observations
do not rule out the possibility that Plcg1 mediates signaling through
other signaling molecules through interaction with its SH3 domain.
Therefore, to investigate this possibility, we performed an in vivo
rescue assay using forms of plcg1 containing point mutations within
the N-SH2 (R581K), C-SH2 (R689K) or SH3 (P837L) domains. Similar
mutations in identical residues in mammalian plcg1 abrogate the
function of these domains and prevent downstream signaling (Ji et al.,
1999; Patterson et al., 2002; Ye et al., 2002). We injected mRNA
encoding mutant forms of plcg1 into embryos derived from an incrossFig. 6. Artery differentiation defects in plcg1 mutants. (A–C) Classiﬁcation schema to cat
interference contrast (DIC) images of zebraﬁsh embryo trunks followingwholemount in situ h
aorta (white arrow). (B)Weak ephrinb2a in distinct patches within the dorsal aorta (white arr
arterymarker gene expression in y13, y16, y18 andMPZy18mutant embryos. (E, F) Transmitte
30 hpf. (E–H) Lateral views, anterior to the left, dorsal is up. (E, G)MPZplcg1y18mutant embryo
denoted absence of deﬁned dorsal aorta or posterior cardinal vein. F, H. Mplcg1y18; Tg(ﬂi1a:eof plcg1y18 heterozygous embryos (Fig. 4F). We then assayed for
segmental artery formation at 30 hpf and circulation at 55 hpf,
followed by PCR-based genotyping. All uninjected plcg1y18 mutant
embryos failed to exhibit segmental artery formation or circulation,
while injection of mRNA encoding wild type Plcg1 rescued these
defects in the majority of mutant embryos (Figs. 4G, H). Injection of
mRNA encoding Plcg1 containing either SH2 mutations failed to
rescue segmental artery formation or circulation (Figs. 4G, H). By
contrast, mutant embryos injected with plcg1 mRNA containing the
P837Lmutation in the SH3 domainwere rescued to a similar degree asegorize level of artery marker gene expression in plcg1 mutant embryos. Differential
ybridization to detect ephrinb2a (efnb2a). (A) Normal ephrinb2a expression in the dorsal
ows). (C) Loss of dorsal ephrinb2a expression classiﬁed as “absent”. (D) Quantiﬁcation of
d light images of embryos at 30 hpf. Scale bar is 250 μM. (G, H) DIC images of embryos at
. Scale bar is 30 μM; nt— neural tube, fp—ﬂoor plate, nc— notochord. Asterisked bracket
gfp)y1 mutant embryo; DA — dorsal aorta, indicated by a bracket.
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dispensable for Plcg1 signaling during vascular development. Taken
together with the characterization of plcg1mutants, our observations
are consistent with a necessary role for Plcg1 catalytic activity
downstream of receptor tyrosine kinases such as Kdrl and Flt4 during
vascular development.
Signaling molecules that can be activated as a result of Vegf
signaling through Plcg1 include Akt and components the MAP kinase
cascade (Zachary and Gliki, 2001). Additionally, recent observations in
zebraﬁsh suggest that MAPK signaling is important for artery
development (Hong et al., 2006). Therefore, we investigated whether
activation of either of these pathways could rescue vascular defects
downstream of plcg1. To activate the MAPK cascade, we expressed a
version of mitogen activated protein kinase kinase 1 (MAP2K1)
containing amino acid substitutions (Ser218NGlu and Ser222NAsp;
referred to hereafter as actMAP2K1; Supplemental Fig. 1) that lead to
20-fold increases in activity of its downstream substrate, MAPK1
(Mansour et al., 1994). Accordingly, embryos injected with mRNA
encoding a mCherry ﬂuorescent protein–actMAP2K1 fusion display
overt defects in development as a consequence of ubiquitous MAPK
activation (Supplemental Fig. 2C–H). To avoid these early develop-
mental effects, we drove expression of mCherry-actMAP2K1 in
endothelial cells using the ﬂi1ep cis element in a Tol2-transposon
backbone (Villefranc et al., 2007). Wild type embryos expressingFig. 7. Plcg1 is required autonomously in endothelial cells for segmental artery sprouting. (A
Lateral views, anterior to the left, dorsal is up. In all images, host cells are expressing dsRedEx
(A–C) donor cells are also labeled with Cascade Blue (blue). (A) Control embryo derived fro
host. Donor contribution to a developing segmental artery (white arrow) and the caudal ve
segmental artery (white arrow) in a plcg1 MO injected Tg(ﬂi1ep:dsredex)um13 host. (C) Don
vein (lumen indicated by awhite bracket) in awild type Tg(ﬂi1ep:dsredex)um13 host. (D) Dono
the dorsal aorta (DA, lumen denoted by a white bracket) in a wild type Tg(ﬂi1ep:dsredex)um
ventral wall of the dorsal aorta (DA, lumen denoted by a white bracket) in a wild type Tg(ﬂmCherry-actMAP2K1 displayed red ﬂuorescence throughout the trunk
vasculature (Figs. 5A–C), including the segmental arteries. In some
cases, segmental arteries expressing high levels of the transgene
appeared to exhibit increased ﬁlopodial activity, while those expres-
sing lower levels were normal (Figs. 5A, B). In plcg1y13 mutant
embryos, cells expressing ﬂi1ep:mCherry-actMAP2K1 could be found
within blood vessels (Figs. 5D–F). However, mCher-actMAP2K1-
positive cells did not form segmental arteries, despite their ability to
contribute to the dorsal roof of the aorta in plcg1y13 mutant embryos
(see arrows in Figs. 5E, F). Similarly, we did not observe circulation in
plcg1y13 mutant embryos expressing ﬂi1ep-driven mCher-actMAP2K1,
even in cases of low transgene mosaicism (data not shown).
To determine if Akt could rescue vascular defects downstream of
plcg1, we expressed a myristoylated form of this kinase that leads to
its constitutive activation (referred to as mAkt, Kohn et al., 1996). To
monitor expression of mAkt, we generated a cassette containing the
viral 2A sequence in between mAkt and monomeric Cherry ﬂuor-
escent protein (mAkt-2A-mCher; Supplemental Fig. 1), allowing
expression of these two separate proteins from a single transcript
(Provost et al., 2007). As with activated MAP2K1, injection of mRNA
encoding mAkt-2A-mCher led to overt defects on embryonic develop-
ment (Supplemental Fig. 2I–L). Therefore, we again used the ﬂi1ep
element to drive expression ofmAkt-2A-mCher in endothelial cells. As
with actMAPK21, we were able to observemAkt-2A-mCher-expressing.–E) Confocal ﬂuorescent micrographs of trunk blood vessels at approximately 27 hpf.
(red), while donor cells are expressing enhanced green ﬂuorescent protein (green); in
m transplantation of wild type donor Tg(ﬂi1a:egfp)y1 cells into a Tg(ﬂi1ep:dsredex)um13
in (white arrowhead) is indicated. (B) Contribution of donor Tg(ﬂi1a:egfp)y1 cells to a
or plcg1-MO injected Tg(ﬂi1a:egfp)y1 cells (white arrows) within the posterior cardinal
r plcg1-MO injected Tg(ﬂi1a:egfp)y1 cells (white arrowheads) within the ventral wall of
13 host. (E) Donor Tg(ﬂi1a:egfp)y1;plcg1y13 mutant cells (white arrowheads) within the
i1ep:dsredex)um13 host. (A–C) Scale bar is 50 μM. (D, E) Scale bar is 30 μM.
Table 2
Number of host Tg(ﬂi1ep:dsredex)um13 embryos displaying donor Tg(ﬂi1a:egfp)y1




WtNwt 8 8 13 13 5
wtNplcg1 MO 5 7 8 15 5
plcg1 MONwt 7 11 3 0 0
plcg1y13Nwt 2 3 0 0 0
Vein — localization in the cardinal or caudal vein; SeA — segmental artery; DLAV —
dorsal longitudinal anastamotic vessel. Total numbers: wt into wt, n= 15; wt into plcg1
MO, n= 27; plcg1 MO into wt, n= 19; plcg1y13 into wt, n= 3.
222 L.D. Covassin et al. / Developmental Biology 329 (2009) 212–226cells in the wild type vasculature of Tg(ﬂi1a:egfp)y1 embryos (data not
shown). Similarly, endothelial cells expressing mAkt-2A-mCher could
localize to the aorta, but failed to initiate segmental artery sprout
formation in plcg1y13mutant embryos (Figs. 5G–I) or rescue circula-
tion (data not shown). Taken together, these results indicate that
activation of either MAPK or Akt signaling alone does not appear to be
sufﬁcient downstream of plcg1 to rescue vascular development.
We have previously reported that plcg1y10 mutant embryos display
only partially penetrant defects in arterial endothelial differentiation,
while defects in circulation and segmental artery formation are
observed in all mutant embryos (Lawson et al., 2003). To determine if
the other alleles of plcg1 lead to similar arterial endothelial differentia-
tion defects, we assayed artery marker gene expression in embryos at
24 hpf, followed by genotypic analysis to identify mutant and wild type
siblings.We observed that differences in artery marker gene expression
could be separated into three phenotypic classes in embryos derived
from plcg1mutant heterozygous incrosses: normal (Fig. 6A), weak (Fig.
6B), or absent (Fig. 6C). Following genotyping, we found that all wild
type siblingembryos displayednormal artery speciﬁc expression of both
ephrinb2a and notch3 (Fig. 6D). By contrast more than half of plcg1y13
and plcg1y18mutant embryos displayed complete loss of or weak artery
marker gene expression, although the remaining mutant embryos
expressed normal levels (Fig. 6D). Consistent with the weaker artery
defects in plcg1y16 mutants, we observed a higher proportion of
ephrinb2a and notch3 expression in these embryos (Fig. 6D).
The partially penetrant defects in artery differentiation suggested to
us that maternally deposited plcg1 transcript (Tsang et al., 2004) could
partially compensate for zygotic loss of plcg1 in our mutants. To
investigate this possibility,we performed germline replacement (Ciruna
et al., 2002) to generate adult zebraﬁsh that would produce plcg1
homozygous null gametes. We then crossed maternal mutant
(Mplcg1y18) and paternal mutant (Pplcg1y18) carriers and observed
progeny embryos for defects in overall morphology, vascular function,
and artery marker gene expression. Embryos derived from
Mplcg1y18×Pplcg1y18 crosses (referred to as MPZplcg1y18) displayed
relatively normal morphology at 30 hpf (Fig. 6E). While collapsed brain
ventricles (arrows in Figs. 6E, F) were evident in MPZplcg1y18 mutant
embryos, other morphological landmarks within the brain, such as the
mid-brain hindbrain boundary were evident, suggesting that Fgf
signaling was normal (Reifers et al., 2000). Incomplete ﬁlling of the
ventricles has been observed in mutants lacking circulation (Lowery
and Sive, 2005) and can be seen in kdrlum6 mutant embryos (see Fig.
3B). Within the trunk of MPZplcg1y18embryos, development of the
neural tube, ﬂoor plate, and notochord, as well as pigmentation,
appeared normal (Fig. 6G). However, all embryos derived from
Mplcg1y18×Pplcg1y18 crosses failed to initiate circulation, displayed a
disorganized dorsal aorta and posterior cardinal vein and exhibited
cardiac edema at 55 hpf (data not shown). By contrast, embryos derived
from a cross between aMplcg1y18 female and awild type Tg(ﬂi1a:egfp)y1
male yielded all normal embryos that did not exhibit any vascular
defects (Figs. 6F, H, data not shown). To determine if maternal plcg1
could rescue arterial speciﬁcation in the absence of zygotic gene
function, we assayed arterymaker gene expression (ephrinb2a and dll4)
in MPZplcg1y18embryos. Interestingly, we observed consistent variation
in the penetrance of artery differentiation defects between twodifferent
Mplcg1y18 female carriers. However, in both cases loss of artery marker
gene expression was more severe in MPZplcg1y18 embryos than in
zygotic plcg1y18 (Fig. 6D). Embryos derived from one of the Mplcg1y18
female carrier failed to express either ephrinb2a or dll4, while nearly
half of the embryos from the second Mplcg1y18 female carrier displayed
weak artery marker gene expression (Fig. 6D). We did not observe
normal artery marker gene expression in any MPZplcg1y18 embryos.
These results suggest that maternal plcg1 contribution alone is largely
dispensable for embryonic development. However, in the absence of
zygotic plcg1, maternal contribution appears capable of providing a
compensatory signal that can rescue artery differentiation.Plcg1 can mediate Vegf receptor signaling in endothelial cell lines
(Takahashi et al., 2001) and our previous work suggests that plcg1 is
required for Vegf responsiveness in zebraﬁsh embryos (Lawson et al.,
2003). However, an endothelial cell autonomous function for plcg1
has not been demonstrated. Therefore, we performed mosaic analysis
using cell transplantation in zebraﬁsh embryos to investigate the
requirement for plcg1 in endothelial cells. For this purpose, we
utilized two endothelial cell-speciﬁc transgenic lines. As a source of
donor cells, we relied on Tg(ﬂi1a:egfp)y1 transgenic embryos. For host
embryos, we used Tg(ﬂi1ep:dsredex)um13 transgenic embryos in which
the ﬂi1ep element (Villefranc et al., 2007) drives expression of the red
ﬂuorescent protein, dsRed-Express, in all endothelial cells. As a
general cell lineage tracer, we injected all donor embryos at the 1-
cell stage with Cascade Blue. At sphere stage, cells were removed from
Tg(ﬂi1a:egfp)y1 donor embryos and transplanted into similarly staged
Tg(ﬂi1ep:dsredex)um13 recipients (Supplemental Fig. 3). We then
assayed for contribution of Egfp-positive donor cells in the red
vasculature of host embryos between 25 to 28 hpf. We ﬁnd that wild
type Tg(ﬂi1a:egfp)y1 donor cells are capable of contributing to all
blood vessel types within the trunk vasculature when transplanted
into wild type Tg(ﬂi1ep:dsredex)um13 recipients (Fig. 7A, Table 2). To
determine if plcg1was required autonomously in endothelial cells, we
generated Plcg1-deﬁcient host by injection of a plcg1 Morpholino
followed by transplantation as described (Supplemental Fig. 3). We
observed that wild type Tg(ﬂi1a:egfp)y1 cells could contribute to
segmental arteries in embryos otherwise lacking plcg1, while host red
ﬂuorescent segmental arteries were not observed (Fig. 7B). This result
indicates that Plcg1 functions autonomously within endothelial cells
to mediate segmental artery sprouting. To determine if plcg1 deﬁcient
cells could contribute to wild type blood vessels, we performed the
converse transplantation experiment. In this case, we co-injected
Plcg1 MO and Cascade Blue to generate plcg1-deﬁcient Tg(ﬂi1a:egfp)y1
donor embryos (Supplemental Fig. 3). In the resulting embryos, we
failed to observe any plcg1 deﬁcient Egfp-positive cells in segmental
arteries (Table 2). However, plcg1-deﬁcient cells were capable of
contributing to other trunk blood vessels, including the dorsal aorta
and posterior cardinal vein (Fig. 7C, Table 2). Interestingly, we found
that plcg1 deﬁcient cells in dorsal aorta were more likely to contribute
to the ventral wall than to the dorsal wall of this blood vessel (Fig. 7D).
Similarly, we observed that transplanted cells mutant for plcg1y13
could localize the ventral wall of the aorta (Fig. 7E, Table 2).
Discussion
In this work we describe a forward genetic approach to identify
vascularmutants using the zebraﬁsh as amodel system. Our screening
strategy combined two particular aspects of the zebraﬁsh model that
proved beneﬁcial: ﬁrst, the use of a transgenic line expressing Egfp in
endothelial cells allowing robust and direct visualization of blood
vessel morphology in live embryos (Lawson and Weinstein, 2002).
Second, the ability to rapidly screen mutagenized genomes by
generating haploid embryos from F1 females. Despite the haploid
genotype in the embryos we were scoring, we found that this
Fig. 8. Model of possible quantitative or qualitative differences of signaling through
Plcg1.
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ment. We were able to identify several speciﬁc classes of vascular
defects in haploid Tg(ﬂi1a:egfp)y1 embryos, including loss of seg-
mental artery formation as well as ectopic branching of these vessels.
It was also possible to identify milder defects in segmental artery
sprouting and these were consistent with phenotypes associated with
hypomorphic mutations in kdrl and plcg1 in diploid embryos. We
observed that the majority of putative haploid mutant phenotypes
were recapitulated in diploid embryos. Furthermore, we eliminated
many other vascular phenotypes during screening based on obvious
morphological defects in other tissues. Consistently, the mutant
phenotypes we observed in diploid Tg(ﬂi1a:egfp)y1 embryos were
speciﬁc to the vascular system. Thus, it is possible to utilize a
transgenic haploid screening strategy in zebraﬁsh to reliably identify
mutations that affect tissue-speciﬁc morphogenetic processes. The
increasing availability of cell type-speciﬁc transgenic lines should
allow this approach to be applied toward the genetic analysis of
morphogenesis or differentiation in other organs and tissues in the
developing zebraﬁsh embryo.
Several groups have previously utilized the zebraﬁsh to identify
mutations affecting cardiovascular function and morphogenesis. In
initial large-scale mutagenesis screens, two groups working in parallel
identiﬁed zebraﬁsh mutants lacking normal circulation using simple
visual inspection by light microscopy (Chen et al., 1996; Stainier et al.,
1996). By using a two-generation screening approach in which
circulatory phenotypes were scored in the progeny of F2 families (a
so-called “F3 screen”), these groups identiﬁed approximately 70 loci
that affected cardiovascular function from nearly 6000 mutagenized
genomes. More recently, Jin et al. (2007) have incorporated transgenic
visualization of endothelial cells into an F3 screening strategy. In this
case, circulatory defects were ﬁrst screened in F3 progeny of non-
transgenic ﬁsh, followed by visualization of the vascular system via
alkaline phosphatase staining. Identiﬁed F2 carriers were then crossed
into the Tg(kdrl:egfp)s843 background (Jin et al., 2005) to visualize the
vasculature inmore detail. This approach led to the identiﬁcation of 30
loci that affected blood vessel formation out of approximately 4000
genomes screened. In each screen, the number of identiﬁed loci also
included mutants that affected other tissues, in addition to blood
vessels. Given that our screen focused on blood vessel speciﬁc defects,
the number of loci per mutagenized genome that we identiﬁed using
the haploid transgenic approach are similar.
The central drawback to F3 screening approaches in zebraﬁsh is
that they are cost- and labor-intensive, require signiﬁcant amounts of
tank space, and generally take up to 5 years to screen sufﬁcient
numbers of mutant genomes. The transgenic haploid screening
approach we describe here can be performed by a small lab group
within a much shorter time frame. Furthermore, conﬁrmation of
diploid phenotypes can be performed in a map-cross background,
making preliminary genetic mapping much more rapid than standard
F3 screens. An obvious drawback of the haploid approach is the
limitation on possible phenotypes that could be observed in a haploid
embryo. In addition, haploid embryos display overt developmental
abnormalities and some mutant phenotypes may be adversely
affected by gene dosage. That being said, the majority of phenotypes
we observed in haploid embryos were evident in diploids and we
were able to identify several different phenotypic classes indicating
that our screening approach was robust and reliable.
Plcg1 has been implicated in a variety of signaling cascades in a
number of different cell types (Rhee, 2001; Wilde andWatson, 2001).
In most cases, Plcg1 functions downstream of receptor tyrosine
kinases through a canonical pathway that entails binding of the Plcg1
SH2 domains to phosphorylated tyrosine residues within activated
receptors, phosphorylation of tyrosine residues on Plcg1 by the
upstream kinase, and subsequent induction of Plcg1 catalytic activity
(Rhee, 2001). More recently, several studies have revealed new
signaling roles for Plcg1 independent of its lipase activity (Patterson etal., 2002; Ye et al., 2002). However, the relevant mode of Plcg1
signaling in vivo and during embryonic development is not clear.
Previously, we had found that plcg1 deﬁcient zebraﬁsh embryos
displayed speciﬁc defects in artery development and failed to respond
to exogenous Vegf (Lawson et al., 2003). Similar vascular defects have
been observed in plcg1 null mouse embryos (Liao et al., 2002) further
suggesting a primary role for plcg1 during Vegf signaling and/or
vascular development. The speciﬁcity of these developmental defects
had been surprising based on the extensive range of signaling
processes in which plcg1 was known to play a role. While maternal
compensation could explain the speciﬁcity of these embryonic
defects, we ﬁnd that this is not the case. Zebraﬁsh embryos lacking
maternal plcg1 develop normally and those that lack zygotic,
maternal, and paternal, plcg1 proceed through gastrulation and are
morphologically indistinguishable from zygotic mutants. We did not
observe phenotypes associated with deﬁciency in other receptor
tyrosine kinase signaling pathways that act early in development,
such as Fgf (Reifers et al.,1998; Tsang et al., 2004) in any of these cases.
These observations suggest that the primary role of plcg1 during
animal development is to mediate development of the vascular
system. Furthermore, our allelic series and structure/function analysis
indicate a canonical mode of Plcg1 signaling downstream of Vegf
receptors. Mutations within conserved residues of the Plcg1 catalytic
domain result in similar defects associated with the putative null y18
allele, suggesting that catalytic activity is indispensable for Plcg1
function during vascular development. Furthermore, mutation of the
N-SH2 domain leads to similar defects while Plcg1 bearing mutations
in either of the SH2 domains fails to rescue the plcg1 mutant
phenotype. Consistent with its presumed role downstream of the Vegf
receptors, we demonstrate that plcg1 function is required autono-
mously within endothelial cells for proper segmental artery develop-
ment and artery differentiation. Taken together with our previous
observations that plcg1 mutant embryos fail to respond to exogenous
Vegf (Lawson et al., 2003), these results indicate that the primary role
for plcg1 during development is to transduce Vegf signaling during
blood vessel formation.
Several lines of evidence indicate that the Vegf signaling pathway
is providing distinct signals to endothelial cells through Plcg1 at
different points during vascular development. We have previously
shown that kdrl and plcg1 are essential for artery differentiation or
speciﬁcation (Lawson et al., 2002, 2003), a process that is known to
occur during mid-somitogenesis stages prior to formation of the
dorsal aorta (Zhong et al., 2001). Our ﬁndings that maternal plcg1
provides a compensatory signal for differentiation but not
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action of a Kdrl/Plcg1 signaling pathway during this earlier time point.
During later segmental artery morphogenesis both kdrl and the
zebraﬁsh Vegf receptor-3 ortholog, ﬂt4, appear to act through plcg1
(Covassin et al., 2006; Lawson et al., 2003) as combined loss of these
receptors recapitulates the segmental artery and circulatory defects
observed in plcg1 mutant embryos. Whether the different combina-
tion of activating receptors (Kdrl versus Kdrl with Flt4) during
differentiation and morphogenesis elicit quantitative or qualitative
differences in signaling through Plcg1 is not known at this time. The
compensatory role of maternal Plcg1 at earlier time points may be
most simply explained by a lower threshold of activation required for
differentiation versus morphogenesis. In this case, Vegf signaling
through Kdrl would lead to lower Plcg1 activity than that associated
with both Kdrl and Flt4 during segmental artery sprouting (Fig. 8A); in
this case higher Plcg1 activity can promote active sprouting, and
presumably concomitant differentiation, while lower levels promote
differentiation only. Alternatively, the formation of different signaling
complexes between the receptors and Plcg1 in these two settings may
lead to the activation of distinct downstream signaling molecules and
corresponding cellular output (Fig. 8B). This possibility would be
consistent with the additional role of Plcg1 as an adaptor protein to
mediate downstream signaling molecules (Wilde and Watson, 2001).
In either case, it is likely that distinct downstream effector molecules
are subsequently acting to drive artery differentiation or morphogen-
esis downstream of Plcg1.
Our characterization of kdrl alleles would support the existence of
qualitatively distinct signaling outputs in these different develop-
mental contexts. The kdrlum6mutation leads to themost severe defects
in both segmental artery formation and circulatory function, as well as
cranial hemorrhage in someheterozygous carriers, suggesting that this
mutation acts as a mild dominant negative. The severity of the
morphogenesis defects in these mutants as compared to the null
kdrlum19 allele suggests that the um6 mutant receptor may block
signaling of multiple Vegf receptors, including ﬂt4, which can
heterodimerize with Vegfr-2 in human endothelial cell lines (Alam
et al., 2004). Themilder effect of the kdrly17mutation,which eliminates
kinase activity (Covassin et al., 2006), is somewhat surprising in this
regard since similar mutations in related receptors yield dominant
negative forms of these molecules (Dumont et al., 1994; Reith et al.,
1990, 1993). Segmental artery formation is more robust in kdrly17
mutants when compared to the null phenotype raising the intriguing
possibility that the Kdrl receptor can function in a kinase independent
manner during segmental artery sprouting. Despite the loss of kinase
activity, the Kdrly17 receptor could still function as an adaptor or
substrate for other kinases, such as Flt4, allowing sufﬁcient, albeit
compromised, activation of plcg1 and relatively normal segmental
artery formation. In this case, the dominant negative um6 mutation
would be predicted to block the interaction between Kdrl and Flt4, or
prevent interactionwith downstream effectors. This model would also
be consistent with the effects of y17 on dorsal aorta morphogenesis,
which appear more severe than those associated with kdrlum19. While
ﬂt4 and kdrl are co-expressed in segmental artery tip cells, there is only
transient co-expression of both transcripts in the dorsal aorta, followed
by potent down-regulation of ﬂt4 expression. Formation of the dorsal
aorta may proceed through the independent function of these
receptors and therefore requires kinase activity of the Kdrl receptor.
Taken together, our results suggest that Vegf/Plcg1 signaling is acting
in distinct signaling contexts during artery differentiation, dorsal aorta
morphogenesis and segmental artery sprouting. Further identiﬁcation
of additional alleles in kdrl, as well as mutations in ﬂt4, will
undoubtedly be helpful to dissect the diverse genetic interactions of
these receptors and to identify downstream effectors that mediate
each of these processes.
The zebraﬁsh has proven to be an ideal model to study vascular
development. The ability to perform forward genetic screens forvascular mutants has led to the identiﬁcation of novel genes and new
insights on how blood vessels form during embryonic development.
Our demonstration that haploid transgenic screening allows reliable
identiﬁcation of vascular mutants will facilitate future screening for
new genes affecting this blood vessel formation. By incorporating new
transgenic lines that are more lineage-restricted within the vascu-
lature, it would be possible to further expand the range of phenotypic
classes that could be identiﬁed. For example, use of artery or vein
restricted transgenes may yield additional classes of mutations that
affect endothelial differentiation without overt defects in vascular
morphogenesis; these mutants would not have been easily identiﬁed
in our screen. While the forward genetic approach has proven
valuable, it is likely that new reverse genetic approaches will begin
to be more widely applied. The size of the zebraﬁsh genome precludes
saturation screening and numerous mutants have now been repeat-
edly isolated from several different screens. The number of genes
expressed in cardiovascular tissue in zebraﬁsh embryos numbers well
over 100, with many more likely to be identiﬁed. Moving forward, a
concerted effort that integrates focused transgene-assisted forward
genetic screens, along with reverse approaches that take advantage of
new technologies (e.g. zinc ﬁnger nucleases for genomemodiﬁcation)
will allow for a comprehensive genetic analysis of endothelial cell
development and vascular morphogenesis.
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